Prefusion glycoprotein F0/pre-F protein (NiV)

Prefusion glycoprotein F0/pre-F protein (NiV) 제품 목록

  • 속성

    Protein (1)

  • 제품 라이브러리

    온라인 (1)

  • 종

    Nipah virus (1)

  • 태그

    His Tag (1)

  • 마커

    Unconjugated (1)

제품 번호종발현 시스템제품 설명단백질 구조순도특성
Nipah virus
HEK293
Nipah virus Pre-Fusion glycoprotein, His Tag (MALS verified)
총 수량1
  • 1

Prefusion glycoprotein F0/pre-F protein (NiV)분자 배경

Hendra virus (HeV) and Nipah virus (NiV) are henipaviruses discovered in the mid-to late 1990s that possess a broad host tropism and are known to cause severe and often fatal disease in both humans and animals. HeV and NiV infect host cells through the coordinated efforts of two envelope glycoproteins. The G glycoprotein attaches to cell receptors, triggering the fusion (F) glycoprotein to execute membrane fusion. G is a type II homotetrameric transmembrane protein responsible for binding to ephrinB2 or ephrinB3 (ephrinB2/B3) receptors. F is a homotrimeric type I transmembrane protein that is synthesized as a premature F0 precursor and cleaved by cathepsin L during endocytic recycling to yield the mature, disulfide-linked, F1 and F2 subunits. Upon binding to ephrinB2/B3, NiV G undergoes conformational changes leading to F triggering and insertion of the F hydrophobic fusion peptide into the target membrane. Subsequent refolding into the more stable post-fusion F conformation drives merger of the viral and host membranes to form a pore for genome delivery to the cell cytoplasm.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Retroviral vector-transduced autologous T cells to express anti-ALPP CARs (TCRCure Biopharma Corporation)Phase 2 ClinicalXinqiao Hospital, Army Medical UniversityOvarian Neoplasms; Endometrial Neoplasms
상세
  • 제품 목록
  • 임상 약물 정보